Navigation Links
NCBiotech Names New President and CEO
Date:8/13/2014

RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2014 /PRNewswire-USNewswire/ -- Douglas L. Edgeton, NCBiotech's senior vice president for financial planning and development with extensive experience in healthcare and economic development, will be the Center's next president and chief executive officer, the Board of Directors announced today.

"Doug's experience demonstrates he knows how to foster an environment that drives small-company growth and job creation," said John Atkins, chairman of the Board of Directors.

Wednesday's announcement caps a six-month search led by board Vice Chairman Jack Cecil.

"Doug's broad background, knowledge of the Center and connections in the state's life science and health community will be key as the Center continues to facilitate job creation and investment in this high-value sector," said Cecil, who is president of Biltmore Farms.

Edgeton was the staff lead on the top-to-bottom examination of NCBiotech operations, requested by the General Assembly and led by former chairman and CEO of GlaxoWellcome Robert A. Ingram. The study documented changes to the Center's structure, staffing and programs following budget cuts. Ingram's committee recommended additional funding for the Center, and the General Assembly increased the Center's appropriation by $1 million this fiscal year.

Prior to joining NCBiotech in 2012, Edgeton was president of the Piedmont Triad Research Park and executive vice president for administration at Wake Forest Baptist Health. There he guided, from concept to completion, the redevelopment of two former Reynolds tobacco warehouses into the state-of-the-art Wake Forest Biotech Place.

Edgeton spent his early career at the University of Alabama at Birmingham, where he held increasingly senior positions, ultimately as the senior associate dean for administration.

"It is an honor to have been selected to lead efforts of the North Carolina Biotechnology Center," Edgeton said.

"Over the past 20 years, my work has focused on developing the ecosystem that advances life science technologies to market. It is easy to see North Carolina is well-positioned to bring solutions to the challenges of healing, feeding and fueling the world. The Biotech Center facilitates these solutions, which have tremendous impact for North Carolina and beyond.

"I look forward to working with all of the companies and people that we serve."

NCBiotech is a private, non-profit corporation supported by the N.C. General Assembly to grow the life science industry.

Editors' Note: Full release and photo available online.


'/>"/>
SOURCE NCBiotech
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
3. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
4. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
5. Codexis Names Wes Bolsen VP and Chief Marketing Officer
6. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
7. Fitzsimons Redevelopment Authority Names New President & CEO
8. Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President
9. Laureate Biopharma Names James D. Utterback to Board of Directors
10. Health Diagnostic Laboratory Names Scott Blackwell Vice President of Corporate Culture
11. Hospira Names John B. Elliot Senior Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 /PRNewswire/ ... the formation of its Medical/Clinical Advisory Board.  This ... veterans who enhance the range and depth of ... of its novel prenatal diagnostic tests.  These experts ... strategic guidance for the company,s product development and ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 14, 2016 "Increase in mobile ... market" The mobile biometrics market is expected to grow ... billion by 2022, at a CAGR of 29.3% between ... such as the growing demand for smart devices, government ... "Software component is expected to grow at ...
(Date:12/8/2016)... -- Singulex, Inc., the leader in Next Generation Immunodiagnostics powered ... and supply agreement with Thermo Fisher Scientific, the world ... to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker which, ... diagnose systemic bacterial infection and sepsis and in ... assessing the risk of critically ill patients for progression ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade is ... Formula One teams in history, exploit biometric data in ... performance and maintain the competitive edge against their rivals ... Avanade has worked with Williams during ... of biometric data (heart rate, breathing rate, temperature and ...
Breaking Biology News(10 mins):